Denizar vianna clap_bio_meeting_rio_dec16th2011 [modo de compatibilidade]
Pad1
Class antiplatele tand fibinolytics
Where is the evidence? PHRM2010 Judith Coombes The University of Queensland/Princess Alexandra Hospital.
Tia
Leriche Fontaine Classification
Casos clinicossca
God, evolution, global warming and heart disease
Core Curr: Peripheral Artery Disease Diagnosis and Management ...
Stavros Apostolakis, MD, PhD University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom; Antithrombotic therapy.
Leadership. Knowledge. Community. Antiplatelet Therapy for the Secondary Prevention of Cerebrovascular Disease Working Group: Ashfaq Shuaib, MD, FRCP;
© Continuing Medical Implementation …...bridging the care gap Post Myocardial Infarction Pharmacotherapy.